Skip to main content
. 2020 May 20;11:981. doi: 10.3389/fimmu.2020.00981

Figure 2.

Figure 2

Median trough immunoglobulin G (IgG) levels and median immunoglobulin dose per 4 weeks among six patients that started of facilitated subcutaneous immunoglobulin (fSCIG) treatment after previous immunoglobulin (SCIG) and intravenous immunoglobulin (IVIG).